期刊文献+

HIV-1 GP41第二优势表位簇在大肠杆菌中的高效表达 被引量:2

THE SECOND IMMUNODOMINANT EPITOPES OF HIV-1 GP41: EFFICIENT EXPRESSION IN E.coli
在线阅读 下载PDF
导出
摘要 ①目的 构建HIV 1SF2株跨膜蛋白GP4 1第二优势表位簇基因的原核高效表达克隆 ,探讨提高原核表达的途径。②方法 根据密码子的兼并性 ,利用PCR 定点突变技术扩增、改造目的基因片段 ,将其与原核表达载体 pGEX4T 2经EcoRⅠ和SalⅠ双酶切、连接 ,重组质粒pGEX4T 2 /SE转化表达宿主菌DH5α,经IPTG诱导表达出目的融合蛋白 ,经SDS PAGE与Western Blot鉴定。③结果 获得了高效表达HIV 1GP4 1第二优势表位谷胱甘肽S 转移酶融合蛋白的重组菌 ;Western Blot鉴定表明 ,重组蛋白具有良好的抗原性和特异性。④结论在原核表达体系中可以高效表达HIV 1GP4 Objective\ To construct an efficiently expressive prokaryotic clone of the second immunodominant epitopes in GP41 of HIV 1 SF2 strains. \ Methods\ According to the principle of the codon degeneracy, by PCR site directed mutagenesis, the target gene was amplified and two rare codons within it were mutated into major codons for E.coli. Then, the target DNA fragments of HIV 1 GP41 and the prokaryotic expression vector pGEX4T 2 were digested by EcoRⅠ and SalⅠ, recombined and the recombinant plasmid was then transformed into E.coli DH5α. After being induced with IPTG, the fusion protein was efficiently expressed which was identified by SDS PAGE and Western Blot. \ Results\ An efficiently expressive clone pGEX4T 2/SE/DH5α has been constructed successfully.\ Conclusion\ The second immunodominant epitopes GST fusion protein can be expressed plentifully in E.coli after being induced with IPTG.
出处 《青岛大学医学院学报》 CAS 2003年第1期7-9,12,共4页 Acta Academiae Medicinae Qingdao Universitatis
基金 山东省卫生厅科研基金资助项目 (课题编号 :1996QY2 1)
关键词 HIV包膜蛋白质GP41 基因表达 免疫优势表位 病毒融合蛋白质类 HIV envelope protein GP41 gene expression immunodominant epitope viral envelope proteins
  • 相关文献

参考文献1

同被引文献24

  • 1赵文锋,徐旭东,吴梧桐.幽门螺杆菌尿素酶B亚单位表位融合肽在大肠杆菌中的表达与纯化[J].药物生物技术,2007,14(4):235-240. 被引量:2
  • 2Constantine N T. Serological tests for the retroviruses: approaching a decade of evolution[ J ]. AIDS, 1993,7 ( 1 ) : 1-13.
  • 3Sven-Holger D, Tomas P, Peter H, et al. Fine mapping of an immunodominant region of the transmembrane protein of the human immunodefieieney virus (HIV-1)[ J]. J Virol Method,1989,25 (2):167- 177.
  • 4Andersson E R, Sandberg R, Lendahl U. Notch signaling : simplici- ty in design, versatility in function [J]. Development, 2011,138 (17) :3593 - 3612.
  • 5Wu G, Wilson G, George J, et al. Modulation of Notch signaling as a therapeutic approach for liver cancer [J]. Curr Gene Ther,2015,15 (2) :171 -181.
  • 6Andersson E R, Lendahl U. Therapeutic modulation of Notch sig- nalling- are we there yet? [J]. Nat Rev Drug Discov,2014,13 (5) :357 -378.
  • 7Chu D,Zheng J,Wang W,et al. Notch2 expression is decreased in coloreetal cancer and related to tumor differentiation status [J]. Ann Surg Onco1,2009,16 ( 12 ) :3259 - 3266.
  • 8Truong M, Cook M R, Pinchot S N, et al. Resveratrol induces Notch2 - mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer[J]. Ann Surg Oncol,2011,18 (5) :1506 - 1511.
  • 9Lee J, Sehrawat A, Singh S V. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells[J]. Breast Cancer Res Treat,2012,136( 1 ) :45 - 56.
  • 10Kim S H,Sehrawat A, Singh S V. Notch2 activation by benzyl iso- thiocyanate impedes its inhibitory effect on breast cancer cell migration [J]. Breast Cancer Res Treat,2012,134 ( 3 ) : 1067 - 1079.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部